COVID-19 antibodies on trial
- PMID: 33087898
- PMCID: PMC7576980
- DOI: 10.1038/s41587-020-0732-8
COVID-19 antibodies on trial
Erratum in
-
Publisher Correction: COVID-19 antibodies on trial.Nat Biotechnol. 2021 Feb;39(2):246. doi: 10.1038/s41587-021-00813-x. Nat Biotechnol. 2021. PMID: 33420496 Free PMC article. No abstract available.
Abstract
With the first readouts of trials of antibodies against COVID-19 appearing and others coming thick and fast, Nature Biotechnology asked a group of experts to comment on the challenges and timelines for these products.
Figures









References
-
- Alsoussi, W. B. et al. J. Immunol. 10.4049/jimmunol.2000583 (2020).
-
- Chi, X. et al. Science10.1126/science.abc6952 (2020).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources